OBJECTIVES: To compare plasma BNP values determined by a conventional-type and a novel-type of BNP assays. DESIGN AND METHODS: Plasma samples (n=94) from HF patients were analyzed by the novel-type "Single Epitope Sandwich" (SES assay prototype) and the conventional-type Siemens ADVIA Centaur BNP assays. Both assays were calibrated using recombinant proBNP (expressed in E. coli). RESULTS: The SES assay measured 1.2- to 7.2-fold (2.1±0.9; mean, SD) greater BNP concentrations compared to the Siemens assay. A subset of six samples (6.4%) demonstrated the largest (3- to 7.2-fold higher) difference. CONCLUSIONS: The SES prototype assay appears to more accurately measure the absolute concentrations of BNP immunoreactive forms.
OBJECTIVES: To compare plasma BNP values determined by a conventional-type and a novel-type of BNP assays. DESIGN AND METHODS: Plasma samples (n=94) from HF patients were analyzed by the novel-type "Single Epitope Sandwich" (SES assay prototype) and the conventional-type Siemens ADVIA Centaur BNP assays. Both assays were calibrated using recombinant proBNP (expressed in E. coli). RESULTS: The SES assay measured 1.2- to 7.2-fold (2.1±0.9; mean, SD) greater BNP concentrations compared to the Siemens assay. A subset of six samples (6.4%) demonstrated the largest (3- to 7.2-fold higher) difference. CONCLUSIONS: The SES prototype assay appears to more accurately measure the absolute concentrations of BNP immunoreactive forms.
Authors: Alexander van Reenen; Mario Berger; Emmanuel Moreau; Edwin Bekx; Tom Bruinink; Danielle Kemper; Lian van Lippen; Jos Weusten; Anita Mrakovic; Etienne Michielsen; Joost Vissers; Femke de Theije; Jeroen Nieuwenhuis; Veronique Semjonow; Johannes Mair Journal: Pract Lab Med Date: 2019-03-17